Literature DB >> 25960839

A Novel Mutation Causing 17-β-Hydroxysteroid Dehydrogenase Type 3 Deficiency in an Omani Child: First Case Report and Review of Literature.

Aisha Al-Sinani1, Waad-Allah S Mula-Abed2, Manal Al-Kindi2, Ghariba Al-Kusaibi2, Hanan Al-Azkawi1, Nahid Nahavandi3.   

Abstract

This is the first case report in Oman and the Gulf region of a 17-β-hydroxysteroid dehydrogenase type 3 (17-β-HSD3) deficiency with a novel mutation in the HSD17B3 gene that has not been previously described in the medical literature. An Omani child was diagnosed with 17-β-HSD3 deficiency and was followed up for 11 years at the Pediatric Endocrinology Clinic, Royal Hospital, Oman. He presented at the age of six weeks with ambiguous genitalia, stretched penile and bilateral undescended testes. Ultrasound showed no evidence of any uterine or ovarian structures with oval shaped solid structures in both inguinal regions that were confirmed by histology to be testicular tissues with immature seminiferous tubules only. The diagnosis was made by demonstrating low serum testosterone and high androstenedione, estrone, and androstenedione:testosterone ratio. Karyotyping confirmed 46,XY and the infant was raised as male. Testosterone injections (25mg once monthly) were given at two and six months and then three months before his surgeries at five and seven years of age when he underwent multiple operations for orchidopexy and hypospadias correction. At the age of 10 years he developed bilateral gynecomastia (stage 4). Laboratory investigations showed raised follicle-stimulating hormone, luteinizing hormone, androstenedione, and estrone with low-normal testosterone and low androstendiol glucurunide. Testosterone injections (50mg once monthly for six months) were given that resulted in significant reduction in his gynecomastia. Molecular analysis revealed a previously unreported homozygous variant in exon eight of the HSD17B3 gene (NM_000197.1:c.576G>A.Trp192*). This variant creates a premature stop codon, which is very likely to result in a truncated protein or loss of protein production. This is the first report in the medical literature of this novel HSD17B3 gene mutation. A literature review was conducted to identify the previous studies related to this disorder.

Entities:  

Keywords:  17-β-Hydroxysteriod Dehydrogenase Type 3 Deficiency; Ambiguous Genitalia; Delta-4-Androstenedione; Disorder of Sex Development, 46,XY; Estrone; HSD17B3 gene; Testosterone

Year:  2015        PMID: 25960839      PMCID: PMC4412451          DOI: 10.5001/omj.2015.27

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  30 in total

1.  17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations.

Authors:  A L Boehmer; A O Brinkmann; L A Sandkuijl; D J Halley; M F Niermeijer; S Andersson; F H de Jong; H Kayserili; M A de Vroede; B J Otten; C W Rouwé; B B Mendonça; C Rodrigues; H H Bode; P E de Ruiter; H A Delemarre-van de Waal; S L Drop
Journal:  J Clin Endocrinol Metab       Date:  1999-12       Impact factor: 5.958

Review 2.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

3.  17-β-hydroxysteroid dehydrogenase type 3 deficiency in three adult Iranian siblings.

Authors:  M D Omrani; T Adamovic; U Grandell; S Saleh-Gargari; Agneta Nordenskjöld
Journal:  Sex Dev       Date:  2011-12-30       Impact factor: 1.824

4.  The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology.

Authors:  F Labrie; V Luu-The; S X Lin; C Labrie; J Simard; R Breton; A Bélanger
Journal:  Steroids       Date:  1997-01       Impact factor: 2.668

Review 5.  Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases.

Authors:  S Andersson; N Moghrabi
Journal:  Steroids       Date:  1997-01       Impact factor: 2.668

6.  Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase 3 deficiency. Diagnosis, psychological evaluation, and management.

Authors:  B B Mendonca; M Inacio; I J Arnhold; E M Costa; W Bloise; R M Martin; F T Denes; F A Silva; S Andersson; A Lindqvist; J D Wilson
Journal:  Medicine (Baltimore)       Date:  2000-09       Impact factor: 1.889

7.  17beta-Hydroxysteroid dehydrogenase-3 deficiency: from pregnancy to adolescence.

Authors:  S Bertelloni; A Balsamo; L Giordani; R Fischetto; G Russo; M Delvecchio; M Gennari; A Nicoletti; M C Maggio; D Concolino; L Cavallo; A Cicognani; G Chiumello; O Hiort; G I Baroncelli; M F Faienza
Journal:  J Endocrinol Invest       Date:  2009-05-12       Impact factor: 4.256

8.  Congenital Adrenal Hyperplasia due to 17-alpha-hydoxylase/17,20-lyase Deficiency Presenting with Hypertension and Pseudohermaphroditism: First Case Report from Oman.

Authors:  Waad-Allah S Mula-Abed; Fathima B Pambinezhuth; Manal K Al-Kindi; Noor B Al-Busaidi; Hilal N Al-Muslahi; Mohammad A Al-Lamki
Journal:  Oman Med J       Date:  2014-01

Review 9.  Overview of genetic defects in endocrinopathies in the island of Cyprus; evidence of a founder effect.

Authors:  Christos Shammas; Vassos Neocleous; Meropi Toumba; Constantina Costi; Alexia A P Phedonos; Elisavet Efstathiou; Andreas Kyriakou; Leonidas A Phylactou; Nicos Skordis
Journal:  Genet Test Mol Biomarkers       Date:  2012-08-02

10.  46,XY disorder of sex development in a sudanese patient caused by a novel mutation in the HSD17B3 gene.

Authors:  Mona Ellaithi; Ralf Werner; Felix G Riepe; Nils Krone; Alexandra E Kulle; Tayseer Diab; Alaa K Kamel; Wiebke Arlt; Paul-Martin Holterhus; Omyma Sabir; Olaf Hiort
Journal:  Sex Dev       Date:  2014-06-12       Impact factor: 1.824

View more
  2 in total

1.  Spectrophotometric and chromatographic strategies for exploring of the nanostructure pharmaceutical formulations which contains testosterone undecanoate.

Authors:  Monica Butnariu; Ioan Sarac; Ionel Samfira
Journal:  Sci Rep       Date:  2020-02-27       Impact factor: 4.379

Review 2.  Disorder of Sex Development Due to 17-Beta-Hydroxysteroid Dehydrogenase Type 3 Deficiency: A Case Report and Review of 70 Different HSD17B3 Mutations Reported in 239 Patients.

Authors:  Catarina I Gonçalves; Josianne Carriço; Margarida Bastos; Manuel C Lemos
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.